Free Trial

Cogent Biosciences (COGT) SEC Filings & 10K Form

Cogent Biosciences logo
$4.37 +0.10 (+2.34%)
Closing price 04:00 PM Eastern
Extended Trading
$4.36 0.00 (-0.11%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cogent Biosciences SEC Filings

DateFilerForm TypeView
04/11/2025
5:28 PM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SCHEDULE 13G/A
02/25/2025
7:38 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
7:20 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
8:28 AM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
01/27/2025
4:03 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Green John L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:55 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Kearns Evan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:56 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Robbins Andrew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:56 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Sachs Jessica (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:58 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Robinson John Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
4:00 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Pinnow Cole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
6:00 AM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Pinnow Cole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
3:21 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Ferrante Karen Jean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
6:59 PM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:47 PM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G/A
11/14/2024
11:24 AM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Kynam Capital Management, LP (Filed by)
Form SC 13G/A
11/07/2024
8:24 AM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/07/2024
8:12 AM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
FMR LLC (Filed by)
Form SC 13G/A
09/03/2024
7:15 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:53 PM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/02/2024
3:31 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:31 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Ferrante Karen Jean (Reporting)
Ferrante Karen Jean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:05 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
6:06 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Morris Arlene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
6:07 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Shegog Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
6:11 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Harwin Peter Evan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
6:14 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Ferrante Karen Jean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
6:14 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
6:18 PM
CAIN CHRISTOPHER W. (Reporting)
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:06 AM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Fairmount Funds Management LLC (Filed by)
Form SC 13D/A
06/12/2024
8:01 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Fairmount Funds Management LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:19 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:26 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2024
3:32 PM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form DEF 14A
04/23/2024
3:34 PM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form DEFA14A
04/23/2024
3:37 PM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form ARS
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:COGT) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners